Novo Holdings
VC
INVESTOR TYPE
Active
STATUS
52
PROFESSIONALS
385
INVESTMENTS
112
PORTFOLIO
147
EXITS
Description
Founded in 1999, Novo Holdings is a corporate venture arm of the Novo Nordisk Foundation headquartered in Hellerup, Denmark. The firm is the holding company for the Novo Group. The firm seeks to invest in the biotechnology, healthcare and life sciences sectors.
Website
Formerly Known As
Nova A/S
Investor Status
Actively Seeking New Investments
Year Founded
1999
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Real Estate
Venture Capital
Primary Office
- Tuborg Havnevej 19
- 2900 Hellerup
- Denmark
+45 35 00 00 00
Novo Holdings Investments (385)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| HepaRegenix | 21-Jan-2020 | Early Stage VC | 000.00 | Drug Discovery | Pre-Clinical Trials | 0000000000 0000000000 00.0 |
| 00000000 000000000 | 08-Jan-2020 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 0ø000 000000 00.0 |
| 000000000 | 07-Jan-2020 | 00000 00000 | 0000 | Biotechnology | Startup | 0ø0000 0ø0000 00000000 |
| 0000000000 0000000 | 06-Jan-2020 | 00000 00000 | 00.00 | Drug Discovery | Product Development | 00000 00000 00.0 |
| 000000000 | 06-Jan-2020 | 00 000000000 | 00.000 | Biotechnology | Generating Revenue | 00000 00000 00.0 |
| 00000000 | 09-Dec-2019 | 00000 00000 | 00.000 | Building Products | Generating Revenue | |
| 000000000 00000000 | 20-Nov-2019 | 00000 00000 | 0000 | Pharmaceuticals | Stealth | |
| 0000-0000000000 00 | 14-Nov-2019 | 0000000000 | 00.000 | Other Healthcare Services | Generating Revenue | |
| Allievex | 23-Oct-2019 | Early Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 2 | 0000 0000000 00.0 |
| eResearch Technology | 21-Oct-2019 | PE Growth/Expansion | Database Software | Profitable | 00000000000 0ø0000000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Novo Holdings’s full profile, request a free trial.
Novo Holdings Exits (145)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Reata Pharmaceuticals | 14-Nov-2019 | Public Investment 2nd Offering | 00000 | Completed |
|
| 000000 00000000000 | 07-Nov-2019 | 000 | 0000 | Completed |
|
| 000000 000 | 11-Sep-2019 | 000000000000000000 | Completed |
|
|
| 000 | 19-Aug-2019 | 000000000000000000 | 00.000 | Completed |
|
| 00000 000000000000 | 18-Jul-2019 | 000 | 0000 | Completed |
|
| 000000000 | 01-Jul-2019 | 000000000000000000 | 00000 | Completed |
|
| 0000000 0000000000 | 27-Jun-2019 | 000 | 0000 | Completed |
|
| 000000 00000000000 | 31-May-2019 | 000000 0000000000 | 00000 | Completed |
|
| Milestone Pharmaceuticals | 13-May-2019 | IPO | 000.00 | Completed |
|
| Affinicon | 01-Feb-2019 | Out of Business | Completed |
|
Novo Holdings Team (108)
36 Former Team Members
You’re viewing 5 of 108 team members. Get the full list »Novo Holdings Co-Investors (205)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| New Enterprise Associates | 8 | 00 | |
| OrbiMed | 0 | 0 | |
| Vivo Capital | 0 | 0 | 0 |
| Sunstone Life Science Ventures | 0 | 0 | |
| Versant Venture Management | 0 | 0 |